Bristol-Myers Squibb Company
BMY · Healthcare · · USDFahodi Score HOLD Long-term (Investment)
57
/ 100
Technical
75
Trend & RS
63
Momentum
56
Fundamental
65
Macro
24
Liquidity
53
| Component | Score | Weight |
|---|---|---|
| Technical | 75.0 | 10% |
| Trend & RS | 62.6 | 10% |
| Momentum | 55.9 | 5% |
| Fundamental | 65.2 | 40% |
| Macro | 23.8 | 15% |
| Liquidity | 53.0 | 20% |
Trade Setup
| Entry | 61.77 |
| Stop Loss | 58.17 (5.8%) |
| Target 1 (1:1) | 65.38 (+5.8%) |
| Target 2 (2:1) | 68.97 (+11.7%) |
| ATR(14) | 1.80 (2.9%) |
| Risk per Share | 3.60 |
| Reward:Risk | 2:1 |
ATR-based levels. Adjust for support/resistance zones.
Factor Profile
| Factor | Score | Z | Bar |
|---|---|---|---|
| Value | 67.6 | +0.70 | |
| Momentum | 55.9 | +0.24 | |
| Quality | 62.7 | +0.51 | |
| Composite | 62.1 | ||
Quality Scores
Piotroski F-Score
6
/9 —
Average
✓
✓
✗
✗
✗
✓
✓
✓
✓
1. Positive Net Income
2. Positive Roa
3. Positive Cfo
4. Quality Earnings
5. Lower Leverage
6. Higher Liquidity
7. No Dilution
8. Higher Gross Margin
9. Higher Asset Turnover
Altman Z-Score
3.19
—
Safe Zone
Distress <1.81Grey 1.81–2.99>2.99 Safe
Valuation vs Peers Fair Value
| Metric | Stock | Sector | vs Peers |
|---|---|---|---|
| P/E Ratio | 14.0 | 22.0 | -36% below |
| P/B Ratio | 5.5 | 4.0 | Above |
| Dividend Yield | 4.0% | 1.5% | Above avg |
Comparing against Healthcare median multiples.
Intrinsic Value (DCF) Fairly Valued
Intrinsic Value
68.65
vs
Market Price
63.13
Upside
+8.7%
| Margin of Safety | +8.0% |
| Stage 1 PV (5yr FCF) | 34,797,947,836 |
| Terminal Value PV | 105,519,372,962 |
| Total Enterprise Value | 140,317,320,798 |
Assumptions
| Base FCF | 7,375,061,678 |
| Growth Rate (5yr) | 6.9% |
| Terminal Growth | 2.5% |
| Discount Rate (WACC) | 9.0% |
2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.
Position Sizing — Kelly Criterion
4.6%
Recommended Size
37.3%
Full Kelly
18.65%
Half Kelly
5.0%
Max Cap (Moderate)
Kelly inputs derived from quant score 57/100. Estimated win rate 57%, avg win 8.4%, avg loss 3.9%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.
RECOVERY
Regime: RECOVERY (40% confidence) — position size reduced 8%
Signal Summary STRONG BUY
3
Bullish Signals
1
Bearish Signals
50.12
RSI(14)
0.3239
MACD
Relative Strength (RS) NEUTRAL
56
/ 99
RS Rating
O'Neil filter: <80
| RS vs SPY | → FLAT (+0.2% vs SPY 3M) |
| RS vs Sector | UNDERPERFORMING (Healthcare) |
| RS New High | No (45d since high) |
| Sector Outperformance | -15.7% (3M) |
RS Line — stock / SPY (90 bars)
← older
newer →
RS vs SPY
50-day SMA of RS
NEUTRAL:
In line with the market — no strong outperformance or underperformance.
Technical Indicators
| Indicator | Value | Signal |
|---|---|---|
| Rsi | 50.12 | NEUTRAL |
| Macd | 0.3239 | BULLISH |
| Ma Cross | 62.34 / 59.64 | GOLDEN CROSS |
| Trend Short | BELOW SMA50 | |
| Trend Long | ABOVE SMA200 | |
| Bollinger | MIDDLE | |
| Volume | 0.02x | LOW |
Key Levels
| Level | Price |
|---|---|
| 52-Week High | 68.64 |
| Bollinger Upper | 64.84 |
| SMA(200) | 59.64 |
| SMA(50) | 62.34 |
| SMA(20) | 61.07 |
| Current Price | 63.13 |
| Bollinger Lower | 57.3 |
| 52-Week Low | 45.27 |
| ATR(14) | 1.8 |
Advanced Technical Analysis
Click to expand
Wyckoff Phase & Volume Spread Analysis
Wyckoff Phase
ACCUMULATION E
Confidence
50%
Acc: 1.0 |
Dist: 1.0 |
Markup: 0.0 |
Markdown: 0.0
Volume Spread Analysis (last 5 bars)
| Date | Signal | Vol | Description |
|---|---|---|---|
| 2026-11-02 | Normal | 0.93x | Normal bar — no special VSA pattern |
| 2026-11-03 | Normal | 0.88x | Normal bar — no special VSA pattern |
| 2026-11-04 | Normal | 1.21x | Normal bar — no special VSA pattern |
| 2026-11-05 | Normal | 0.77x | Normal bar — no special VSA pattern |
| 2026-11-06 | No Supply | 0.02x | Low volume, narrow spread, firm close — no selling pressure |
Ichimoku Cloud NEUTRAL
| Line | Value | Status |
|---|---|---|
| Tenkan-sen (9) | 62.77 | Above Kijun |
| Kijun-sen (26) | 60.84 | Base line |
| Senkou A | 61.81 | Leading span A |
| Senkou B | 62.19 | Leading span B |
| Cloud | 61.81 – 62.19 | Bearish (Red) |
| Price vs Cloud | 61.77 | Below Cloud |
| Chikou Span | 61.15 | Bullish |
| Alignment Score | 2/4 | NEUTRAL |
TTM Squeeze & Divergences
TTM Squeeze
SQUEEZE OFF
No squeeze
Momentum:
BULLISH FADING
BB: 57.3 – 64.84 | KC: 58.07 – 64.07
Divergences (last 60 bars)
| Type | Indicator | Bars Ago | Strength |
|---|---|---|---|
| Hidden Bearish | RSI | 12 |
Anchored VWAP
VWAP: 57.69
Anchor: 2025-11-20 (52w Low)
ABOVE AVWAP
+7.1%
Heikin-Ashi Trend
WEAKLY BEARISH
Full data via /api/advanced/BMY
Valuation
| Metric | Value |
|---|---|
| Market Cap | 129.04B |
| P/E (TTM) | 14.00 |
| Forward P/E | N/A |
| P/B | 5.51 |
| EPS | 4.51 |
Financial Health
| Metric | Value |
|---|---|
| Revenue Growth | 6.9% |
| Profit Margin | 18.5% |
| ROE | 44.0% |
| Debt/Equity | 191.46 |
| Current Ratio | 1.59 |
| Dividend Yield | 4.0% |
| Payout Ratio | N/A |
| Beta | 0.19 |
Trading Data
63.13
Open
63.13
Day High
63.13
Day Low
9.00M
Volume (0.8x avg)
Price Chart (90 Days)
Candlesticks (green=up, red=down)
SMA 20
SMA 50
Bollinger Bands (upper/lower)
Volume (green=buying, red=selling)